Cardiac Arrest News and Research

Latest Cardiac Arrest News and Research

Researchers find new way to boost survival of pediatric patients suffering cardiac arrest

Researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital Stanford have found a new way to boost the survival of pediatric patients whose hearts stop while they are hospitalized.

16 Jan 2014

EC grants approval for ABRAXANE in combination with gemcitabine for metastatic pancreatic cancer

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that the European Commission has granted approval for ABRAXANE (paclitaxel formulated as albumin bound nanoparticles, or nab-paclitaxel) in combination with gemcitabine for first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas, or metastatic pancreatic cancer.

7 Jan 2014

Study explores safety and efficacy of scoop and run approach in Philadelphia

A new study from the Perelman School of Medicine at the University of Pennsylvania has found no significant difference in adjusted overall survival rates between gunshot and stabbing (so-called penetrating trauma injuries) victims in Philadelphia whether they were transported to the emergency department by the police department or the emergency medical services division of the fire department.

3 Jan 2014

Surgeons develop iPad app to capture trauma patient data in low medical resource environment

Electronic health records have become standard practice throughout hospitals in North America, but in countries with fewer resources many front-line clinicians are still collecting data on paper, if they are collecting it at all. But now, surgeons from Vancouver, British Columbia, have developed a way for their peers at a Level I trauma center in South Africa to accurately collect and analyze trauma care data via an iPad app. The study is published in the January issue of the Journal of the American College of Surgeons.

2 Jan 2014

Texas Children's Hospital recognized as first Accredited Pediatric Heart Failure Institute in Texas

Texas Children's Hospital is proud to be named the first Accredited Pediatric Heart Failure Institute in Texas by The Healthcare Accreditation Colloquium. The Colloquium made the announcement following nearly a year of work and an in-depth onsite review on Dec. 16.

21 Dec 2013

New projects advance treatments for radiation syndrome, cardiac arrest-induced brain injury and rare blood disorder

The National Institutes of Health today has launched three pre-clinical projects to advance potential new treatments for acute radiation syndrome, brain injury following cardiac arrest and a rare blood disorder called beta thalassemia.

17 Dec 2013

Conventional echocardiography increases accuracy of pre-participation sports screening

Echocardiography with conventional M-mode and 2D modalities is a simple and cost effective way to increases the accuracy of pre-participation sports screening, according to research presented at EuroEcho-Imaging 2013 by Dr Alexander Kisko from Presov, Slovakia.

14 Dec 2013

Groundbreaking UVA research receives $3.3M NIH grant to increase lungs for transplantation

Groundbreaking research at the University of Virginia School of Medicine that aims to dramatically increase the number of lungs that can be used for transplant has received a $3.3 million grant from the National Institutes of Health.

13 Dec 2013

Study: Unfolded protein response can increase risk of sudden cardiac death

A researcher at the Cardiovascular Institute (CVI) at Rhode Island, The Miriam and Newport hospitals has found a link to human heart failure that if blocked, may reduce the risk of sudden cardiac death.

3 Dec 2013

CHMP adopts positive opinion for ABRAXANE with gemcitabine for treatment of metastatic pancreas

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that the European Medicines Agency's: Committee for Medicinal Products for Human Use has adopted a positive opinion for ABRAXANE (paclitaxel formulated as albumin bound nanoparticles, or nab-paclitaxel) in combination with gemcitabine for first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas.

25 Nov 2013

Higher 36°C temperature as effective as 33°C for therapeutic hypothermia treatment

Therapeutic hypothermia - cooling the body and brain down to 33-C - is the method used worldwide to treat cardiac arrest, even though a lower body temperature may raise the risk of side-effects. However, keeping the temperature steady at 36-C is just as effective, a study led by Lund University researchers has found.

20 Nov 2013

Study assesses CPR with mechanical chest compression in patients with out-of-hospital cardiac arrest

Sten Rubertsson, M.D., Ph.D., of Uppsala University, Sweden and colleagues assessed whether cardiopulmonary resuscitation in which chest compressions are delivered with a mechanical device would result in superior 4-hour survival in patients with out-of-hospital cardiac arrest compared to CPR with manual chest compression.

19 Nov 2013

Lowering body temperature improves survival, neurological outcome in cardiac arrest patients

Francis Kim, M.D., of Harborview Medical Center, Seattle, and colleagues evaluated whether early prehospital cooling (lowering body temperature) improved survival to hospital discharge and neurological outcome in cardiac arrest patients with or without ventricular fibrillation (VF).

19 Nov 2013

Annual rates of CPR training vary widely across the U.S.

Annual rates of CPR training in the United States are low and vary widely across the country, but the communities most in need of training are the least likely to be trained, according to a new study from the Duke Clinical Research Institute.

19 Nov 2013

TOPCAT trial results of spironolactone presented at AHA Scientific Sessions

A late-breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial, to be presented at the American Heart Association Scientific Sessions, November 18, 2013, demonstrates that spironolactone did not reduce the primary outcome of cardiovascular death, heart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump function). However, spironolactone did reduce the major burden faced by these patients-the risk of repeated hospitalizations for heart failure.

19 Nov 2013

Cardiac Arrest News and Research

Latest Cardiac Arrest News and Research

Researchers find new way to boost survival of pediatric patients suffering cardiac arrest

EC grants approval for ABRAXANE in combination with gemcitabine for metastatic pancreatic cancer

Study explores safety and efficacy of scoop and run approach in Philadelphia

Surgeons develop iPad app to capture trauma patient data in low medical resource environment

Texas Children's Hospital recognized as first Accredited Pediatric Heart Failure Institute in Texas

New projects advance treatments for radiation syndrome, cardiac arrest-induced brain injury and rare blood disorder

Conventional echocardiography increases accuracy of pre-participation sports screening

Groundbreaking UVA research receives $3.3M NIH grant to increase lungs for transplantation

Study: Unfolded protein response can increase risk of sudden cardiac death

CHMP adopts positive opinion for ABRAXANE with gemcitabine for treatment of metastatic pancreas

Higher 36°C temperature as effective as 33°C for therapeutic hypothermia treatment

Study assesses CPR with mechanical chest compression in patients with out-of-hospital cardiac arrest

Lowering body temperature improves survival, neurological outcome in cardiac arrest patients

Annual rates of CPR training vary widely across the U.S.

TOPCAT trial results of spironolactone presented at AHA Scientific Sessions

Grave prognosis for heart patients with treatment-resistant hypertension

Children who suffer cardiac arrest while hospitalized are more likely to die during night shift

Prolonged CPR can improve patient's chance of surviving cardiac arrest

ZOLL Medical announces establishment of ZOLL Foundation

Livers from donors with pre-hospital cardiac arrest considered for transplant

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Cardiac Arrest News and Research

Latest Cardiac Arrest News and Research

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in